"There were weeks and weeks when we didn't see a single vessel at all, either on the horizon or on our AIS chart plotter system." Talking about managing Cystic Fibrosis whilst on the expedition ...

Credit: Yuri Milner. Global divisions and existential challenges threaten humanity's progress at precisely the moment when ...

look at its stock chart. Shares of the innovative biotech company have soared almost 20% year to date. Why is Vertex faring so well? The big biotech company markets the only approved therapies that ...

Vertex Pharmaceuticals is strutting toward its Q1 earnings report with a 22.3% stock surge this year, brushing up against its 52-week high. While analysts expect a dip in earnings per share, revenue ...

We look back on the stars who died this year, including Gene Hackman, Michelle Trachtenberg, Val Kilmer, Angie Stone, David ...

BiomX Inc. advanced stock charts by Barron's. View PHGE historical stock data and compare to other stocks, and exchanges.

The management of CF has been changing drastically over the last few years, especially after the introduction of CFTR modulators. Currently, 188,336 people have the disease in 96 countries, but only ...

A new study supports the clinical utility of human nasal epithelial cultures as predictive biomarkers for cystic fibrosis CFTR modulator therapy.

Seven recommendations developed, including use of floating immunoreactive trypsinogen cutoff over fixed cutoff.

Seven recommendations developed, including use of floating immunoreactive trypsinogen cutoff over fixed cutoff. HealthDay News — In a guideline issued by the US Cystic Fibrosis Foundation and ...

MONDAY, April 14, 2025 (HealthDay News) -- Current newborn screening for cystic fibrosis favors white children over those ...